Skip to main content

and
  1. Article

    Open Access

    Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer

    Limited understanding of the cancer biology of metastatic sites is a major factor contributing to poor outcomes in cancer patients. The regional lymph nodes are the most common site of metastasis in most solid...

    Abdi Ghaffari, Victoria Hoskin, Gulisa Turashvili, Sonal Varma in Breast Cancer Research (2019)

  2. Article

    Open Access

    Erratum to: “A novel role for ezrin in breast cancer angio/lymphangiogenesis”

    Abdi Ghaffari, Victoria Hoskin, Alvin Szeto, Maaike Hum in Breast Cancer Research (2015)

  3. Article

    Open Access

    A novel role for ezrin in breast cancer angio/lymphangiogenesis

    Recent evidence suggests that tumour lymphangiogenesis promotes lymph node metastasis, a major prognostic factor for survival of breast cancer patients. However, signaling mechanisms involved in tumour-induced...

    Abdi Ghaffari, Victoria Hoskin, Alvin Szeto, Maaike Hum in Breast Cancer Research (2014)

  4. Article

    Open Access

    Activated Stat5 levels do not increase with cell density in contrast to activated Stat3 levels in breast epithelial cell culture

    Jamaica D Cass, Mulu Geletu, Sandip SenGupta, Bruce E Elliott in BMC Proceedings (2013)

  5. Article

    Open Access

    Ezrin is required for adhesion and migration in invasive breast cancer

    Alvin Szeto, Victoria Hoskin, Bruce E Elliott in BMC Proceedings (2013)

  6. Article

    Open Access

    Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells

    The membrane cytoskeletal crosslinker, ezrin, a member of the ERM family of proteins, is frequently over-expressed in human breast cancers, and is required for motility and invasion of epithelial cells. Our gr...

    Hannah Mak, Alexandra Naba, Sonal Varma, Colleen Schick, Andrew Day in BMC Cancer (2012)

  7. Article

    Open Access

    A novel activating role of SRC and STAT3 on HGF transcription in human breast cancer cells

    We have previously determined that the HGF promoter can be transactivated by a combination of activated Src and wild-type Stat3 in the mouse breast cell lines HC11 and SP1. To determine if this pathway is of r...

    Michelle R Sam, Bruce E Elliott, Christopher R Mueller in Molecular Cancer (2007)

  8. Article

    Open Access

    The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells

    The membrane cytoskeletal crosslinker ezrin participates in several functions including cell adhesion, motility and cell survival, and there is increasing evidence that it regulates tumour progression. However...

    Bruce E Elliott, Jalna A Meens, Sandip K SenGupta, Daniel Louvard in Breast Cancer Research (2005)

  9. No Access

    Chapter

    Tumor specific antigens induced by mutagens and DNA hypomethylating agents: implications for the immunobiology of neoplasia

    The effusive enthusiasm that characterized so much of tumor immunology research during the 1960’s and 1970’s has gradually given way to a widespread and pervasive cynicism. One could cite many reasons for this...

    Robert S. Kerbel, Philip Frost in Cancer Immunology: Innovative Approaches t… (1986)

  10. No Access

    Article

    Receptor specificity, functional characteristics, and cell-surface phenotype of a highly selected anti-I-Ab-specific, long-term T-cell line

    A highly selected alloreactive T-cell line was developed by repeated restimulation of B10.D2/n lymph-node cells with irradiated C57BL/10Sn (BIO) spleen cells in long-term MLC for up to 2 1/2 years. Continuous ...

    Bruce E. Elliott, Arthur Kimura, Ammon B. Peck, Zoltan A. Nagy in Immunogenetics (1981)

  11. No Access

    Article

    Antigen-binding receptors on T cells from long-term MLR. Evidence of binding sites for allogeneic and self-MHC products

    Antibody inhibition of radiolabelled stimulator membrane vesicle binding by T blasts activated in the mixed lymphocyte reaction (MLR) was used to identify responder-cell determinants involved in the binding ph...

    Bruce E. Elliott, Zoltan A. Nagy, Bela J. Takacs, Yinon Ben-Neriah in Immunogenetics (1980)

  12. No Access

    Article

    Alloactivated Lyt 1 +2 T lymphoblasts bind syngeneic Ia antigens

    A large proportion of T blasts activated in the mixed lymphocyte reaction (MLR) is capable of binding plasma membrane (PM) vesicles prepared from the stimulator strain1,2. The binding of vesicles is specific, and...

    Bruce E. Elliott, Zoltan A. Nagy, Yinon Ben-Neriah, David Givol in Nature (1980)